Matinas Biopharma
MTNB0.296610.66% ( -0.0354 )
Q1 FY2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Overview: Matinas Biopharma(MTNB) the EBIT is -1.936 M (+0.51%);the EPS is -0.3 (+7.89%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
EBIT
-0.00B0.51%
----
----
EPS
-0.29997.89%
----
----
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf